Endocrine Research Updates

For Medical Professionals

With 9 endpoints of gastric, metabolic and bariatric surgeries identified, clinicians will have targeted results to utilize in guiding patients in the selection or avoidance of invasive weight loss procedures.
In promoting a patient-centered approach to diabetes care, endocrinologists are urged to assess mental state of patients as a means to better outcomes.
Guidelines to foster better risk assessment for bone fracture, and more aggressive strategies for osteoporosis inpatients on glucocorticoid therapy
Clinicians may have clear markers to guide prescribing decisions with regard to those at highest risk of developing diabetes—a risk that appears to be very low for most, but not all.
Clinicians have 2 clear markers that may predict who's at highest risk of developing diabetes:
Clinicians should follow women who develop gestational diabetes and intervene early to reduce risk for cardiovascular diseases.
Clinical Practice for Iodine Supplementation during Preconception, Pregnancy, and Lactation Lags Behind Medical Society Recommendations
Iodine supplementation for women of childbearing age, pregnancy and breastfeeding is recommended but 3 in 4 practitioners do not followed the prescribed recommendations.
Non-Invasive Imaging may reduce need for removal of benign thyroid nodules.
Using FDG-PET in combination with sonographic features may improve diagnosis of indeterminate thyroid nodules that are benign, aiming for fewer surgeries.
Researchers found that Sitagliptin and Metformin therapy may prevent hyperglycemic relapses in obese African Americans
Treatment with pioglitazone, a thiazolidinedione, acts as a preventive agent in individuals with insulin sensitivity who are at elevated risk for cardiovascular disease.
Results may needlessly worry some, researcher says; others call it an urgent need to alert Americans early and get them the medical care necessary to avoid costly care later
Despite the known efficacy and value, the range of available weight loss medications remain underutilized and inadequately prescribed
Scientific consensus demands action to protect the public from the known adverse impact of commonly occurring, endocrine-disrupting chemicals (EDCs) found in the environment.
new weight loss device prompts sustained weight loss
Reduced comorbid risk factors and improved satiety reported with minimal side effects, using the first new obesity therapy to receive FDA device approval in 9 years
Hyperthyroid Guidelines
Expert task force revises the 5-year old clinical care guidelines to reflect critical advances in patient management
diabetes extra income
AADE superstars share their strategies for creating alternative revenue streams
Two top diabetes educators offer strategies for CDEs to earn more income.
Elderly female receiving an injection from the Doctor
With Paul Miller, MD, Anne R. Cappola, MD, ScM, and Dolores M. Shoback, MD
Daily injection of the synthetic peptide abaloparatide for 18 months significantly reduced the risk of new vertebral and nonvertebral fractures in postmenopausal women with osteoporosis at high risk of fracture.
Close-up of patient hands measuring glucose level blood test with glucomete
Lead Author Matthew J. O’Brien, MD and Priyathama Vellanki, MD Comment
The detection of dysglycemia was found to be lower among racial/ethnic minorities using the new 2015 United States Preventive Services Task Force prediabetes and diabetes screening guidelines.
Stack of colorful magazines against a white background
Lead author David S. Cooper, MD and John C. Morris, III, MD Comment
Research in the field of thyroid disease is thriving with a third of all papers on this topic being published in the last 10 years, according to an analysis in the August issue of Thyroid.
Woman having an ultrasound test performed on the thyroid
Senior Author Julie A. Sosa, MD and Robert C. Smallridge, MD comment
While patients with pT1a and pT1b differentiated thyroid cancer underwent different treatment strategies during the last decade, survival outcomes were similar, according to a retrospective analysis in the August issue of Thyroid.
Young boy having his blood drawn for testing
Task Force vice chair David Grossman, MD, MPH; Douglas K. Owens, MD, MS; and, Robert H. Eckel, MD provide comments
The U.S. Preventive Services Task Force (USPSTF) reviewed evidence for screening asymptomatic children and adolescents for both familial hypercholesterolemia and multifactorial dyslipidemia.